Dr. Anna Nikolaidou | Nanomedicine | Best Researcher Award

Posted on by ScienceFather

Dr. Anna Nikolaidou | Nanomedicine | Best Researcher Award

Dr. Anna Nikolaidou, National and Kapodistrian University of Athens, Greece

Dr. Anna Nikolaidou 🩺✨ is a Greek ophthalmologist and researcher specializing in nanomedicine and retinal diseases. Currently a Myopia Research Fellow in Tübingen, Germany 🇩🇪, she explores the visual impact of removing chromatic aberration in emmetropes and myopes. With an MD from Aristotle University of Thessaloniki (graduated with honors 🎓), she holds two MSc degrees focusing on medical research methodology and nanomedicine. Dr. Nikolaidou has published in renowned journals, combining artificial intelligence 🤖 and teleophthalmology 📡 to advance retinal disease diagnosis. Her innovative work bridges cutting-edge science and patient care 🌟, making her a rising leader in ophthalmology.

Professional  Profile:

Scopus

Orcid

Suitability Summary

Dr. Anna Nikolaidou is an exemplary candidate for the Best Researcher Award due to her outstanding contributions to ophthalmology, nanomedicine, and retinal disease research. Her pioneering work bridges cutting-edge science, such as nanotechnology and artificial intelligence (AI), with clinical practice, advancing diagnosis, treatment, and care for complex eye conditions. With multiple academic achievements, prestigious research fellowships, and innovative projects in AI-based retinal disease diagnosis and nanomedicine, Dr. Nikolaidou has demonstrated leadership, innovation, and impact in her field.

Education and Experience

  • 🎓 MSc in Nanomedicine (2023 – Ongoing)
    Thesis: Utilization of Nanoparticles for Treating Age-related Macular Degeneration.
  • 🎓 MSc in Medical Research Methodology (2021 – 2023)
    Thesis: AI Algorithms for Retinopathy of Prematurity Diagnosis.
  • 🎓 Doctor of Medicine (MD) (2015 – 2021)
    Aristotle University of Thessaloniki – Graduated Excellent (9.47/10).
  • 🩺 Myopia Research Fellow (2024 – Present)
    Institute of Ophthalmic Research, Tübingen, Germany.
  • 👁️ Ophthalmology Resident (2023 – 2024)
    Aghia Sophia Children’s Hospital, Greece.
  • 🔬 Research Fellow (2022 – 2023)
    LIFE4LV Project (ClinicalTrials.gov Identifier: NCT05184036).

Professional Development

Dr. Nikolaidou’s career integrates innovation and research 🌐. She has contributed to AI-based retinal disease diagnosis 🤖 and teleophthalmology 📡, enhancing ophthalmic care post-COVID-19. At Moorfields Eye Hospital, she studied medical retina and genetics 🔬. Her award-winning work includes systematic reviews on glaucoma management and space medicine. Through conference presentations 🎤 at prestigious platforms, including the American Academy of Ophthalmology 🇺🇸, and publications in high-impact journals 📚, she continues to shape the future of eye care. Dr. Nikolaidou’s passion for nanotechnology and theranostics demonstrates her commitment to blending science and clinical practice for global health 🌍.

Research Focus

Dr. Nikolaidou focuses on nanomedicine 🧬, applying nanoparticles for retinal disease treatment. Her research delves into AI algorithms 🤖 for diagnosis, particularly retinopathy of prematurity and space medicine 🚀. At the forefront of ophthalmology, she examines the removal of chromatic aberration for better visual outcomes 👁️. Her innovative projects emphasize theranostics 🩻, integrating diagnostics and treatment. Through interdisciplinary collaboration 🌐, she contributes to advancing retinal care, leveraging teleophthalmology 📡 and cutting-edge imaging technologies 🖥️. With a commitment to addressing complex eye conditions, her work aims to improve diagnosis, management, and patient outcomes globally 🌍.

Awards and Honors

  • 🏆 Presented research at the American Academy of Ophthalmology and European Pediatric Ophthalmology Congress.
  • 🥇 Recognized for innovative AI-based research on retinal diseases and space medicine.
  • 🏅 Published impactful studies in prestigious journals like Journal of Glaucoma and Brain & Development.
  • 🌟 Honored for contributions to teleophthalmology and post-COVID ophthalmic care strategies.

Publication Top Notes:

  • Virtual Reality With Eye Tracking for Pediatric Ophthalmology: A Systematic Review
  • 📄 The Effect of Phacoemulsification on the Intraocular Pressure of Patients With Open Angle Glaucoma: A Systematic Review and Meta-Analysis

    🔗 2 Citations

  • 📄 Neuropsychiatric manifestations associated with Juvenile Systemic Lupus Erythematosus: An overview focusing on early diagnosis

    🔗 2 Citations

  • 📄 Investigation of Sleep Quality and Mental Health of Greek Physicians During the COVID-19 Pandemic
  • 📄 Microgravity induced resting state networks and metabolic alterations during sleep onset

    🔗 1 Citation

 

Dr. Fernando Novio | Nanodrugs Awards | Best Researcher Award

Posted on by ScienceFather

Dr. Fernando Novio | Nanodrugs Awards | Best Researcher Award

Dr. Fernando Novio | Nanodrugs Awards | Best Researcher Award

Fernando Novio is an Associate Professor in the Chemistry Department at Universitat Autónoma de Barcelona (UAB). Born on May 5th, 1976, he holds a BSc in Chemistry (2000) and a Master’s degree (2002) from the University of Santiago de Compostela, and a Ph.D. in Chemistry from UAB (2007). His research expertise lies in the field of Inorganic Chemistry, with a focus on Bioinorganic and Nanomedicine. He has held postdoctoral positions at the Laboratoire de Chimie de Coordination in Toulouse and the Catalan Institute of Nanoscience and Nanotechnology (ICN2-CSIC). In December 2022, he secured a permanent position at UAB, where he leads a research group specializing in the development of nanostructured coordination polymers for therapeutic and diagnostic applications, particularly in brain diseases. Over his career, Novio has published 58 scientific papers, presented over 100 communications at conferences, and contributed to several European projects and patents. His work is widely recognized, with an h-index of 25 and approximately 1,400 citations. He has also been an editor of a scientific book and regularly reviews for prestigious journals.

Professional Profile:

Scopus

Google Scholar

Suitability Summary for Best Researcher Award:

Summary of Suitability: Dr. Fernando Novio is a highly qualified candidate for the Best Researcher Award, given his extensive academic background, research experience, and significant contributions to the fields of Inorganic Chemistry, Bioinorganic Chemistry, and Nanomedicine. His educational journey, beginning with a BSc in Chemistry (2000) and a Master’s degree (2002) from the University of Santiago de Compostela, culminated in a Ph.D. in Chemistry from Universitat Autónoma de Barcelona (UAB) in 2007. This strong foundation has enabled him to excel in his research career, particularly in developing coordination polymers for therapeutic and diagnostic applications, with a focus on brain diseases.

🎓Education:

Fernando Novio completed his BSc in Chemistry in 2000, followed by a Master’s degree in Chemistry in 2002, both from the University of Santiago de Compostela. He later pursued his Ph.D. in Chemistry at Universitat Autónoma de Barcelona (UAB), which he successfully completed in 2007.

🏢Work Experience:

After earning his Ph.D. in Chemistry, Fernando Novio undertook a postdoctoral position at the Laboratoire de Chimie de Coordination in Toulouse, France, where he worked from 2008 to 2011. He then continued his research as a postdoctoral researcher at the Catalan Institute of Nanoscience and Nanotechnology (ICN2-CSIC) in Barcelona, Spain, from 2011 to 2022. In December 2022, he was appointed as an Associate Professor in the Chemistry Department at Universitat Autónoma de Barcelona (UAB).

🏆Awards:

Fernando Novio has been honored with the Best Researcher Award at the International Research Awards, recognizing his significant contributions to the field. Additionally, he has received recognition for his work in Nanomedicine and Bioinorganic Chemistry, further highlighting his impact and achievements in these specialized areas of research.

Publication Top Notes:

  • Comparative study of frequency-dependent dielectric properties of ferrites MFe2O4 (M = Co, Mg, Cr and Mn) nanoparticles
    • Cited by: 58
  • NiFe2O4 nanoparticles/MWCNTs nanohybrid as anode material for lithium-ion battery
    • Cited by: 57
  • Nanohybrids of multi-walled carbon nanotubes and cobalt ferrite nanoparticles: High performance anode material for lithium-ion batteries
    • Cited by: 24
  • Nanocomposites of multi-walled carbon nanotubes/cobalt ferrite nanoparticles: synthesis, structural, dielectric and impedance spectroscopy
    • Cited by: 20
  • Annealing Induced Enhancement in Magnetic Properties of Co0.5Zn0.5Fe2O4 Nanoparticles
    • Cited by: 14

 

 

Prof. Jamal Sabir | Nanomedicine Awards | Best Researcher Award

Posted on by ScienceFather

Prof. Jamal Sabir | Nanomedicine Awards | Best Researcher Award

Prof. Jamal Sabir , King Abdulaziz University , Saudi Arabia

Jamal Sabir M Sabir, a Saudi Arabian native born in Taif, holds a distinguished academic background. He earned his Bachelor’s degree in Biology (Zoology) from King Abdulaziz University in 1980, followed by a Master’s degree in Biology (Genetics) from the same institution in 1984. His academic journey culminated in a Ph.D. in Genetics and Biotechnology from Sussex University, UK, in 1992. Dr. Sabir’s career progression reflects his dedication to academia, starting as a Demonstrator at King Abdulaziz University in 1980 and rising to the rank of Professor in 2014. His scientific pursuits encompass diverse areas, including the induction of genetic mutations, genotoxicity studies of pesticides and heavy metals, and biotechnology research. Dr. Sabir has supervised numerous postgraduate projects, focusing on mutagenic effects, cytogenetics, molecular evaluations, and genomic analyses. His contributions extend to bioremediation efforts for oil pollutants and the molecular genetic study of human breast cancer. Dr. Sabir’s extensive scientific activities underscore his commitment to advancing genetic research and biotechnology in Saudi Arabia and beyond.

Professional Profile:

Scopus

Education:

Jamal Sabir M Sabir earned his Bachelor’s degree in Biology (Zoology) from King Abdulaziz University in Saudi Arabia in 1980. He continued his studies at the same institution, obtaining a Master’s degree in Biology (Genetics) in 1984. Dr. Sabir then pursued his Ph.D. in Genetics and Biotechnology at Sussex University in Brighton, UK, completing it in 1992

Work Experience:

Dr. Jamal Sabir M Sabir’s career at King Abdulaziz University in Saudi Arabia began in 1980 when he was appointed as a Demonstrator in the Faculty of Science. He advanced to the position of Lecturer in 1986. In 1992, Dr. Sabir was promoted to Assistant Professor, followed by a promotion to Associate Professor in 2001. His academic achievements and dedication to research and teaching led to his promotion to full Professor in 2014.

Publication Top Notes:

  • Synthesis of biocomposites from microalgal peptide incorporated polycaprolactone/κ-carrageenan nanofibers and their antibacterial and wound healing property
    • Authors: Raghunathan, S., Kandasamy, S., Balakrishna Pillai, A., Kim, J.-W., Davoodbasha, M.
    • Journal: International Journal of Pharmaceutics, 2024
  • Synthesis and characterization of hydroxy propyl methyl Cellulose/Copper nanobiocomposites for antibacterial and antioxidant smart materials
    • Authors: Davoodbasha, M., Raghunathan, S., Mohammed Yasin, A., Lee, S.-Y., Kim, J.-W.
    • Journal: Journal of Molecular Liquids, 2024
  • Identification and Characterization of HIRIP3 as a Histone H2A Chaperone
    • Authors: Ignatyeva, M., Patel, A.K.M., Ibrahim, A., Sabir, J.S.M., Hamiche, A.
    • Journal: Cells, 2024
  • Next generation sequencing shows diversity of Omicron sub-lineages of SARS-COV2 circulating in Jeddah, Saudi Arabia
    • Authors: Bouna, A., Atef, A., Al-Mahdi, H.B., Rather, I.A., Sabir, J.S.M.
    • Journal: Journal of King Saud University – Science, 2024
  • MBD4 loss results in global reactivation of promoters and retroelements with low methylated CpG density
    • Authors: Papin, C., Ibrahim, A., Sabir, J.S.M., Bronner, C., Hamiche, A.
    • Journal: Journal of Experimental and Clinical Cancer Research, 2023
    • Citations: 1